Home › Companies › AGILON HEALTH INC. › 2023-2024

AGILON HEALTH INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and AGILON HEALTH INC.’s Form 8-K, filed June 3, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 5Ballot items
  • 189Asset managers
  • 1,468Fund votes
  • May 29, 2024Meeting date

Results at a glance

Meeting of May 29, 2024: 5 items on AGILON HEALTH INC.’s Form 8-K, filed June 3, 2024: 3 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore AGILON HEALTH INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by AGILON HEALTH INC.

These tallies are AGILON HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AGILON HEALTH INC. — official shareholder meeting results, meeting held May 29, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Ravi Sachdev 359,574,46625,246,100106,890 --7,698,907 93%Elected—
Elect Director: Steven J. Sell 362,777,06322,042,462107,931 --7,698,907 94%Elected—
Elect Director: William Wulf, M.D. 359,928,89424,926,63371,929 --7,698,907 94%Elected—
2. Ratification of Independent Registered Public Accounting Firm 391,453,8081,087,70284,853 ---- 99.7%Approved—
3. Non-Binding Vote on Executive Compensation 318,678,23666,152,44496,776 --7,698,907 83%Approved—

Source: AGILON HEALTH INC., Form 8-K, filed with the SEC on June 3, 2024 — read the filing on EDGAR.

How asset managers voted at the AGILON HEALTH INC. 2023-2024 meeting

Each item below shows how the 189 asset managers that disclosed a AGILON HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Ravi Sachdev

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 359,574,466AGAINST: 25,246,100
Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: Election of Class III Directors: Ravi Sachdev

AGILON HEALTH INC.’s own tally for this item (“Elect Director: Ravi Sachdev”): 359,574,466 for, 25,246,100 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class III directors until the Company's 2027 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 203,220,010 for, 3,156,774 against.

FOR
FOR: 203,220,010AGAINST: 3,156,774
Largest asset managers voting on “Election of Class III Directors: Ravi Sachdev” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group46,216,0420 00For
Fidelity40,874,8780 00For
Morgan Stanley20,711,8554,493 00For
NEW ECONOMY FUND9,195,9600 00For
Hartford6,920,9290 00For
Brighthouse3,178,1794,581 00For
AMCAP FUND2,895,4180 00For
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS01,016,618 00Against
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds0815,161 00Against
Equitable649,59770,523 00Mixed
Principal0317,160 00Against
John Hancock226,6267,015 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs0175,435 00Against
AGF Investments Trust0165,508 00Against
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert0144,974 00Against
Guardian Variable Products Trust129,6070 00For
TIAA0125,247 00Against

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

2. Elect Director: Steven J. Sell

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 362,777,063AGAINST: 22,042,462
Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: Election of Class III Directors: Steven J. Sell

AGILON HEALTH INC.’s own tally for this item (“Elect Director: Steven J. Sell”): 362,777,063 for, 22,042,462 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class III directors until the Company's 2027 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 203,584,811 for, 2,791,973 against.

FOR
FOR: 203,584,811AGAINST: 2,791,973
Largest asset managers voting on “Election of Class III Directors: Steven J. Sell” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group46,216,0420 00For
Fidelity40,874,8780 00For
Morgan Stanley20,711,8554,493 00For
NEW ECONOMY FUND9,195,9600 00For
Hartford6,920,9290 00For
Brighthouse3,178,1794,581 00For
AMCAP FUND2,895,4180 00For
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS01,016,618 00Against
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds0815,161 00Against
Equitable720,1200 00For
Principal0317,160 00Against
John Hancock226,6267,015 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs0175,435 00Against
AGF Investments Trust0165,508 00Against
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert0144,974 00Against
Guardian Variable Products Trust129,6070 00For
TIAA125,2470 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

3. Elect Director: William Wulf, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 359,928,894AGAINST: 24,926,633
Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: Election of Class III Directors: William Wulf, M.D.

AGILON HEALTH INC.’s own tally for this item (“Elect Director: William Wulf, M.D.”): 359,928,894 for, 24,926,633 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class III directors until the Company's 2027 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 203,337,806 for, 3,038,978 against.

FOR
FOR: 203,337,806AGAINST: 3,038,978
Largest asset managers voting on “Election of Class III Directors: William Wulf, M.D.” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group46,216,0420 00For
Fidelity40,874,8780 00For
Morgan Stanley20,711,8554,493 00For
NEW ECONOMY FUND9,195,9600 00For
Hartford6,920,9290 00For
Brighthouse3,178,1794,581 00For
AMCAP FUND2,895,4180 00For
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS01,016,618 00Against
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds0815,161 00Against
Equitable649,59770,523 00Mixed
Principal0317,160 00Against
John Hancock226,6267,015 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs0175,435 00Against
AGF Investments Trust0165,508 00Against
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert0144,974 00Against
Guardian Variable Products Trust129,6070 00For
TIAA0125,247 00Against

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

4. 3. Non-Binding Vote on Executive Compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

83% Approved · of votes cast

FOR 83%AGAINST
FOR: 318,678,236AGAINST: 66,152,444
Details: description as filed, official tally, votes by 189 asset managers

Description as filed by funds: To approve, by advisory vote, the compensation paid to the Company's named executive officers.

AGILON HEALTH INC.’s own tally for this item (“3. Non-Binding Vote on Executive Compensation”): 318,678,236 for, 66,152,444 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 - Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers.”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 58 asset managers voting on “To approve, by advisory vote, the compensation paid to the Company's named executive officers.” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group046,216,042 00Against
Fidelity40,874,8780 00For
Morgan Stanley20,716,3480 00For
NEW ECONOMY FUND09,195,960 00Against
Hartford6,920,9290 00For
Brighthouse3,182,7600 00For
AMCAP FUND02,895,418 00Against
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS1,016,6180 00For
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds815,1610 00For
Equitable720,1200 00For
Principal317,1600 00For
John Hancock233,6410 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs175,4350 00For
AGF Investments Trust165,5080 00For
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert144,9740 00For
Guardian Variable Products Trust129,6070 00For
TIAA125,2470 00For

Fund voting reports, all 58 managers: 148,062,293 for, 58,314,437 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 149 asset managers voting on “To approve, by advisory vote, the compensation paid to the Company's named executive officers.” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Clayton, Dubilier & Rice, LLC100,000,0000 00For
Capital Group1,06862,616,801 00Against
Wellington52,076,5580 00For
Morgan Stanley46,716,2690 00For
Fidelity40,167,0150 00For
Rock Springs Capital Management LP7,347,7920 00For
BlackRock5,309,0170 00For
State Street2,792,2370 00For
GEODE CAPITAL MANAGEMENT, LLC2,746,9520 00For
Bridgewater2,642,6900 00For
Charles Schwab2,231,4650 00For
BROWN ADVISORY INC2,050,1700 00For
Daventry Group, LP1,750,2490 00For
T. Rowe Price1,619,9240 00For
Northern Trust1,012,1810 00For
Durable Capital Partners LP976,1330 00For
Man Group plc750,2200 00For
Amundi0737,772 00Against
Capital Research Global Investors0697,459 00Against
Sessa Capital IM, L.P.599,8750 00For
Vanguard443,1440 00For
Goldman Sachs431,2090 00For
UBS0370,362 00Against
Two Sigma326,0470 00For
AGF MANAGEMENT LTD267,6800 00For

Institutional-manager reports, all 149 managers: 275,818,784 for, 64,810,272 against, 56,342 abstained. Showing the 25 largest; see all in the interactive database.

5. 2. Ratification of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.7% Approved · of votes cast

FOR 99.7%
FOR: 391,453,808AGAINST: 1,087,702
Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.

AGILON HEALTH INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 391,453,808 for, 1,087,702 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 206,376,784 for.

FOR
FOR: 206,376,784
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting” at AGILON HEALTH INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard63,385,8370 00For
Capital Group46,216,0420 00For
Fidelity40,874,8780 00For
Morgan Stanley20,716,3480 00For
NEW ECONOMY FUND9,195,9600 00For
Hartford6,920,9290 00For
Brighthouse3,182,7600 00For
AMCAP FUND2,895,4180 00For
BlackRock2,585,6420 00For
Charles Schwab2,104,3500 00For
Transamerica1,587,8890 00For
DWS1,016,6180 00For
T. Rowe Price952,0990 00For
Northwestern Mutual840,4530 00For
Brown Advisory Funds815,1610 00For
Equitable720,1200 00For
Principal317,1600 00For
John Hancock233,6410 00For
RENAISSANCE CAPITAL GREENWICH FUNDS191,1220 00For
Goldman Sachs175,4350 00For
AGF Investments Trust165,5080 00For
MASTER INVESTMENT PORTFOLIO149,2430 00For
Calvert144,9740 00For
Guardian Variable Products Trust129,6070 00For
TIAA125,2470 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

Largest AGILON HEALTH INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 410,843,000 shares outstanding at the time of that meeting.

Fund voting reports: top AGILON HEALTH INC. shareholders by shares voted on “To approve, by advisory vote, the compensation paid to the Company's named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 15.43%
2Capital Group 11.25%
3Fidelity 9.95%
4Morgan Stanley 5.04%
5NEW ECONOMY FUND 2.24%
6Hartford 1.68%
7Brighthouse 0.77%
8AMCAP FUND 0.70%
9BlackRock 0.63%
10Charles Schwab 0.51%
Institutional-manager reports: top AGILON HEALTH INC. shareholders by shares voted on “To approve, by advisory vote, the compensation paid to the Company's named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Clayton, Dubilier & Rice, LLC 24.34%
2Capital Group 15.24%
3Wellington 12.68%
4Morgan Stanley 11.37%
5Fidelity 9.78%
6Rock Springs Capital Management LP 1.79%
7BlackRock 1.29%
8State Street 0.68%
9GEODE CAPITAL MANAGEMENT, LLC 0.67%
10Bridgewater 0.64%

Reported AGILON HEALTH INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

AGILON HEALTH INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
CD&R Vector Holdings, L.P. 24.34% DEF14A
FMR LLC 14.79% DEF14A
Wellington Management 13.83% 13F
Capital World Investors 13.44% DEF14A
Morgan Stanley 10.66% DEF14A
Vanguard Group 5.91% 13F
BlackRock 5.89% 13F
FMR (Fidelity) 3.81% 13F
Goldman Sachs 1.65% 13F
State Street 1.26% 13F

Percentages above are of 410,843,000 shares outstanding, as reported by AGILON HEALTH INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AGILON HEALTH INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At AGILON HEALTH INC.'s shareholder meeting held May 29, 2024, in the 2023-2024 proxy season, 189 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,468 separate fund positions. On the most widely held item on that ballot — To approve, by advisory vote, the compensation paid to the Company's named executive officers. — AGILON HEALTH INC.'s filing reports the proposal as approved, with 83% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AGILON HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2024.

AGILON HEALTH INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.